North America Cold Sore Treatment Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Cold Sore Treatment Market Analysis

  • Pharmaceutical
  • Published Report
  • Feb 2023
  • North America
  • 350 Pages
  • No of Tables: 58
  • No of Figures: 46

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of NORTH AMERICA Cold Sore Treatment MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. THERAPEUTICS LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drug type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Epidemiology
  6. market overview
    1. drivers
      1. Growing prevalence of cold sore infection
      2. Proliferation in modes of transmission of herpes simplex virus
      3. Increasing awareness about sexually transmitted diseases
      4. Availability of generic drugs
      5. Rising rate of HSV infection among women
    2. RESTRAINTS
      1. Patent termination of marketed drugs
      2. Risks of other diseases associated with cold sore
      3. Dearth of awareness about the onset and symptoms of cold sore treatment
    3. OPPORTUNITIES
      1. Increasing disposable income
      2. Strategic Initiatives by market players
      3. Increasing research and Development
      4. Increasing use of cold sore patches
    4. CHALLENGES
      1. Rise in alternative treatments
      2. Emergence of drugs resistant to acyclovir
      3. Side effects Associated with medications used for treating cold sore
  7. COVID-19 IMPACT ON COLD SORE TREATMENT MARKET
    1. impact on price
    2. Impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. strategic decisions for manufacturers
    5. CONCLUSION
  8. north america COLD SORE TREATMENT MARKET, BY strain TYPE
    1. overview
    2. HERPES SIMPLEX TYPE 1 VIRUS
    3. HERPES SIMPLEX TYPE 2 VIRUS
  9. north america COLD SORE TREATMENT MARKET, BY therapeutics
    1. overview
    2. ANTIVIRAL AGENTS
      1. Acyclovir
      2. Famciclovir
      3. Penciclovir
      4. Valacyclovir
      5. Docosanol
    3. ANALGESIC AGENTS
      1. Carmex
      2. Herpecin
      3. others
    4. others
  10. north america COLD SORE TREATMENT MARKET, BY drug type
    1. overview
    2. generics
      1. otc
      2. prescription
    3. branded
      1. prescription
      2. otc
  11. north america COLD SORE TREATMENT MARKET, BY dosage type
    1. overview
    2. Oral
      1. Tablets
      2. Pills
    3. TOPICAL
      1. cream
      2. Ointments
      3. Gel
      4. spray
    4. others
  12. North america COLD SORE TREATMENT MARKET, BY end user
    1. overview
    2. HOme care
    3. HOspitals
    4. SPECIALTY CLINICS
    5. OTHERS
  13. north america COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. Hospitals Pharmacy
    3. online Pharmacy
    4. RETAIL Pharmacy
  14. north america Cold sore treatment market, by country
    1. overview
      1. U.S.
      2. CANADA
      3. MEXICO
  15. north america Cold Sore Treatment Market: COMPANY landscape
    1. company share analysis: north america
  16. SWOT
  17. company profile
    1. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. FOUNDATION CONSUMER HEALTHCARE
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. NOVARTIS AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. AMNEAL PHARMACEUTICALS LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. APOTEX INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. CIPLA LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. HRA PHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. MERIX PHARMACEUTICAL CORP.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. SQAUREX
      1. 17.15.1 COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. SUN PHARMACEUTICAL INDUSTRIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. VIATRIS INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  18. questionnaire
  19. related reportS

List of Table

TABLE 1 COLD SORE TREATMENT Market, pipeline analysis

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 north america COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)

TABLE 4 north america COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)

TABLE 5 north america ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)

TABLE 6 north america Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 7 north america COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)

TABLE 8 north america generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 9 north america branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 10 north america COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)

TABLE 11 north america Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 12 north america TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 13 north america COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)

TABLE 14 north america COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)

TABLE 15 north america cold sore treatment market, country, 2021-2028 (USD Million)

TABLE 16 U.S. cold sore treatment market, By strain type , 2021-2028 (USD MILLION )

TABLE 17 U.S. cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 18 U.S. anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 19 U.S. analgesics agents in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 20 U.S. cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 21 U.S. Generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 22 U.S. branded in cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 23 U.S. cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 24 U.S. oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 25 U.S. topical in cold sore treatment market, By dosage type, 2018-2027 (USD Million)

TABLE 26 U.S. cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 27 U.S. cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 28 CANADA cold sore treatment market, By testing Type, 2021-2028 (USD MILLION )

TABLE 29 CANADA cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 30 CANADA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 31 CANADA analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 32 CANADA cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 33 CANADA generics in cold sore treatment market, By drug type Type, 2021-2028 (USD Million)

TABLE 34 CANADA branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 35 CANADA cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 36 CANADA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 37 CANADA topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 38 canada cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 39 CANADA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)

TABLE 40 MEXICO cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )

TABLE 41 MEXICO Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )

TABLE 42 MEXICO anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 43 MEXICO analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)

TABLE 44 MEXICO cold sore treatment market, By drug type , 2021-2028 (USD Million)

TABLE 45 MEXICO generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)

TABLE 46 MEXICO branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)

TABLE 47 MEXICO cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 48 MEXICO oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 49 MEXICO topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)

TABLE 50 Mexico cold sore treatment market, By end user, 2021-2028 (USD Million)

TABLE 51 MEXICO cold sore treatment market, By distribution type, 2021-2028 (USD Million)

List of Figure

FIGURE 1 NORTH AMERICA COLD SORE TREATMENT MARKET: SEGMENTATION

FIGURE 2 north america COLD SORE TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 north america Cold Sore Treatment Market: DROC ANALYSIS

FIGURE 4 north america Cold Sore Treatment market: north america VS country MARKET ANALYSIS

FIGURE 5 north america Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 north america Cold Sore Treatment MARKET: MULTIVARIATE MODELLING

FIGURE 7 north america Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 north america COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 north america COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 north america Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID

FIGURE 11 north america Cold Sore Treatment market: SEGMENTATION

FIGURE 12 Growing PREVALENCE OF COLD SORE TREATMENT, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE north america Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the north america COLD SORE TREATMENT MARKET in 2021 & 2028

FIGURE 14 u.s. is the fastest growing market FOR the Cold Sore Treatment MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA COLD SORE TREATMENT MARKET

FIGURE 16 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016

FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016

FIGURE 18 north america COLD SORE TREATMENT market: BY strain TYPE, 2020

FIGURE 19 north america COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)

FIGURE 20 north america COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)

FIGURE 21 north america COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE

FIGURE 22 north america COLD SORE TREATMENT market: BY THERAPEUTICS, 2020

FIGURE 23 north america COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)

FIGURE 24 north america COLD SORE TREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)

FIGURE 25 north america COLD SORE TREATMENT market: BY THERAPEUTICS, LIFELINE CURVE

FIGURE 26 north america COLD SORE TREATMENT market: BY drug type, 2020

FIGURE 27 north america COLD SORE TREATMENT market: BY drug type 2020-2028 (USD Million)

FIGURE 28 north america COLD SORE TREATMENT market: BY drug type, CAGR (2021-2028)

FIGURE 29 north america COLD SORE TREATMENT market: BY drug type, LIFELINE CURVE

FIGURE 30 north america COLD SORE TREATMENT market: BY dosage type, 2020

FIGURE 31 north america COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)

FIGURE 32 north america COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)

FIGURE 33 north america COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE

FIGURE 34 north america COLD SORE TREATMENT market: BY END USER, 2020

FIGURE 35 north america COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)

FIGURE 36 north america COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)

FIGURE 37 north america COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE

FIGURE 38 north america COLD SORE TREATMENT market: BY distribution channel, 2020

FIGURE 39 north america COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)

FIGURE 40 north america COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)

FIGURE 41 north america COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE

FIGURE 42 NORTH AMERICA cold sore treatment market: SNAPSHOT (2020)

FIGURE 43 NORTH AMERICA cold sore treatment market: BY country (2020)

FIGURE 44 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)

FIGURE 45 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)

FIGURE 46 NORTH AMERICA cold sore treatment market: BY strain type (2021-2028)

FIGURE 47 north america cold sore treatment market: company share 2020 (%)

Frequently Asked Questions

The market is segmented based on North America Cold Sore Treatment (for HSV 1 Virus) Market, By Product Type (Medications, Ointments, Creams, Medicated Lip Balms, Cold Sore Patches, and Non-Medicated Products), Route of Administration (Oral, Topical, and Others), Type (Prescription Drugs and Over The Counter (OTC) Drugs), Gender (Male and Female), Drug Type (Branded and Generics), End User (Hospitals, Specialty Clinics, Homecare Setting, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others) - Industry Trends and Forecast to 2030. .
The North America Cold Sore Treatment Market size was valued at USD 446.54 USD Billion in 2022.
The North America Cold Sore Treatment Market is projected to grow at a CAGR of 5.6% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, and Mexico.